Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « because »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
became < because < become  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000007 (2020) Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl[How to manage giant cell arteritis].
000046 (2020) Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000144 (2020) Wolfgang F. Richter [Suisse] ; Hans-Peter Grimm [Suisse] ; Marie-Hélène Gouy [Suisse] ; Susi S Gaard [Danemark] ; Caroline Kreuzer [Suisse] ; Uwe Wessels [Allemagne] ; Dragomir Draganov [Suisse] ; Chris Muenzer [Suisse] ; Tonio Hoche [Suisse]Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.
000206 (2020) Christos Koutsianas ; Konstantinos Thomas ; Dimitrios VassilopoulosReactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000221 (2020) Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000225 (2020) Ali Rismanbaf [Iran]Potential Treatments for COVID-19; a Narrative Literature Review
000272 (2020) Jinwen Lin ; Shiping Yu ; Rending Wang ; Jianghua ChenMulticentric Castleman’s disease in a renal allograft recipient: a case report and literature review
000277 (2020) Sergiu Pasca [Roumanie] ; Ancuta Jurj [Roumanie] ; Bobe Petrushev [Roumanie] ; Ciprian Tomuleasa [Roumanie] ; Daniela Matei [Roumanie]MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
000310 (2020) Guoqiang Zhang [République populaire de Chine] ; Hayato Iwase [États-Unis] ; Liaoran Wang [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Abhijit Jagdale [États-Unis] ; David Ayares [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hidetaka Hara [États-Unis]Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?
000324 (2020) Sae Ochi [Japon] ; Kazuyoshi Saito [Japon] ; Fumitaka Mizoguchi [Japon] ; Shigeaki Kato [Japon] ; Yoshiya Tanaka [Japon]Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
000326 (2020) Phillip Sommer ; Elvedin Lukovic [États-Unis] ; Eliot Fagley [États-Unis] ; Dustin R. Long [États-Unis] ; Julia B. Sobol [États-Unis] ; Katherine Heller ; Vivek K. Moitra [États-Unis] ; Ronald Pauldine [États-Unis] ; Michael F. O Onnor ; Sajid Shahul ; Mark E. Nunnally ; Avery TungInitial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago
000339 (2020) Hsin-Yun Sun [Taïwan] ; Jann-Yuan Wang [Taïwan] ; Yee-Chun Chen [Taïwan] ; Po-Ren Hsueh [Taïwan] ; Yi-Hsuan Chen [Taïwan] ; Yu-Chung Chuang [Taïwan] ; Chi-Tai Fang [Taïwan] ; Shan-Chwen Chang [Taïwan] ; Jung-Der Wang [Taïwan]Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan
000361 (2020) Kunihiko Umekita ; Akihiko OkayamaHTLV-1 Infection and Rheumatic Diseases
000389 (2020) Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro SudoExpression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
000392 (2020) S. P. Mollan [Royaume-Uni] ; K. Paemeleire [Belgique] ; J. Versijpt [Belgique] ; R. Luqmani ; A. J. Sinclair [Royaume-Uni]European Headache Federation recommendations for neurologists managing giant cell arteritis
000394 (2020) Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro AlaibacEruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000403 (2020) Hiroki Hoshino [Japon] ; Yoko Shirai [Japon] ; Hiroe Konishi [Japon] ; Takashi Yamamura [Japon] ; Norikazu Shimizu [Japon]Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
000420 (2020) Chihiro Iwao [Japon] ; Kunihiko Umekita [Japon] ; Shunichi Miyauchi [Japon] ; Masatoshi Kimura [Japon] ; Yuki Rikitake [Japon] ; Koushou Iwao [Japon] ; Mao Rikitake [Japon] ; Ayako Aizawa [Japon] ; Takeshi Kawaguchi [Japon] ; Yumi Kariya [Japon] ; Motohiro Matsuda [Japon] ; Ichiro Takajo [Japon] ; Kazutaka Shiomi [Japon] ; Akihiko Okayama [Japon]Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
000424 (2020) Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis]Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France.
000436 (2020) Jiali Liu [République populaire de Chine] ; Xiaoliang Jin [République populaire de Chine] ; Fang Zhou [République populaire de Chine] ; Hongzhu Chen [République populaire de Chine] ; Wenjie Wang [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Guangji Wang [République populaire de Chine] ; Kun Hao [République populaire de Chine] ; Jingwei Zhang [République populaire de Chine]Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A-mediated drug hepatotoxicity.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "because" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "because" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    because
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021